All posts by: Michael Zand

About Michael Zand

Israeli scientists successfully treat cancer tumor using ‘nano-factory’ tech – TechnoChops (press release) (blog)

Continue reading

2018-02-19 NEWS

TechnoChops (press release) (blog)

Israeli scientists successfully treat cancer tumor using ‘nano-factory’ tech
TechnoChops (press release) (blog)
The Israeli scientists successfully developed artificial cells or “nano-factories” that produce proteins from within the tissue, thereby battling cancer tumors. Details of the technique — tested in both lab cell cultures and in mice and found

Continue reading

2018-02-19 NEWS

UTSA Today

Max and Minnie Tomerlin Voelcker Fund propels stem cell research at UTSA
UTSA Today
With its generosity and belief in the power that science has to improve ordinary lives, the Voelcker Fund is aiding UTSA in bringing stem cell and regenerative medicine research to new heights. The fund’s support is advancing UTSA research to generate

Continue reading

2018-02-19 NEWS

pharmaphorum

Groundbreaking lung cancer approval a big boost for AZ’s Imfinzi
pharmaphorum
AstraZeneca’s immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients. The company announced on Friday that the FDA had approved the drug’s use in patients with unresectable Stage III non
Astrazeneca shares bounce back after cancer drug approval …The Times
US clears AZ’ Imfinzi for lung cancerPharmaTimes
Dr. Schwartz on the Results of the PACIFIC TrialOncLive

all 31 news articles »

Continue reading

2018-02-19 NEWS

AzerNews

Azerbaijan plans to create center of stem cells – AzerNews
AzerNews
Azerbaijan is planning the formation of a new culture of health care for human beings, as academician-secretary of the Department of Biological and Medical Sciences of ANAS, academician Ahliman Amiraslanov said that it’s high time to create a center of

and more »

Continue reading

2018-02-19 NEWS

Nasdaq

AstraZeneca’s immunotherapy drug wins key lung cancer approval
Nasdaq
AstraZeneca still hopes to catch up in the advanced lung cancer market too, by combining Imfinzi with another immunotherapy drug called tremelimumab. Initial results from a clinical trial testing this combination proved disappointing last July, but the
Immunotherapy Drug Wins Key Lung Cancer OK | Newsmax.comNewsmax
Astrazeneca shares bounce back after cancer drug approvalThe Times

all 27 news articles »

Continue reading

2018-02-19 NEWS

Brinkwire

Horsepox synthesis: A case of the unilateralist’s curse?
Bulletin of the Atomic Scientists
The possibility that synthetic biology could be used to produce dangerous pathogens (including smallpox) has been expressly discussed for more than a decade. In 2014, the World Health Assembly commissioned a report on the public health implications of
Did Pox Virus Research Put Potential Profits Ahead of Public Safety?Brinkwire (press release)

all 2 news articles »